Frankie Ann Holmes, MD, a physician at Texas Oncology, discusses neoadjuvant endocrine therapy for patients with breast cancer.
Frankie Ann Holmes, MD
Advertisement
Articles by Frankie Ann Holmes, MD
Advertisement
Latest Updated Articles
Dr. Holmes Discusses Late Recurrence and the MA.17R Trial in Breast CancerPublished: July 30th 2016 | Updated:
- Dr. Frankie Ann Holmes on Duel Anti-HER2-Directed Therapy in Breast Cancer
Published: August 10th 2016 | Updated:
Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast CancerPublished: September 1st 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
2025 Data Across Gynecologic, Lung, and Hematologic Cancers Reshape Treatment Landscapes
4
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
5